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Users of health services should receive accurate information on
the effectiveness, risks, and limitations of medical interventions
in order to be able to actively participate in decision making.1
Ensuring that the target group of a screening programme
receives accurate information about benefits and harms of
screening presents particular challenges. Most people targeted
for screening are free from disease and not in regular contact
with health services. Participation in screening programmes
must therefore be actively promoted to achieve high coverage.
Indeed, in one study the perceived benefits of mammography
screening were found to be predictive of participation in Caucasian
(but not in African American) women, and another study, also
based on the Health Beliefs Model, reported that perceived
benefits accounted for a substantial proportion of the variance
between women who wanted a mammogram and women who
did not.2,3 Of note, some have argued that women who are not
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Background Screening programmes are often actively promoted to achieve high coverage,
which may result in unrealistic expectations. We examined women’s understand-
ing of the likely benefits of mammography screening.
Methods Telephone survey of random samples of the female population aged 15 years in
the US, UK, Italy, and Switzerland using three closed questions on the expected
benefits of mammography screening.
Results A total of 5964 women were contacted and 4140 women (69%) participated.
Misconceptions were widespread: a majority of women believed that screening
prevents or reduces the risk of contracting breast cancer (68%), that screening at
least halves breast cancer mortality (62%), and that 10 years of regular screening
will prevent 10 or more breast cancer deaths per 1000 women (75%). In multi-
variate analysis higher number of correct answers was positively associated with
higher educational status (odds ratio [OR] = 1.44, 95% CI: 1.25, 1.66) and negatively
with having had a mammography in the last 2 years (OR = 0.86, 95% CI: 0.73,
1.01). Compared with US women (reference group) and Swiss women (OR = 0.98,
95% CI: 0.82, 1.18) respondents in Italy (OR = 0.61, 95% CI: 0.50, 0.74) and the
UK (OR = 0.73, 95% CI: 0.60, 0.88) gave fewer correct answers.
Conclusion In the US and three European countries a high proportion of women over-
estimated the benefits that can be expected from screening mammography. This
finding raises doubts on informed consent procedures within breast cancer
screening programmes.
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complying with screening recommendations ‘would benefit
from additional emphasis on mammography benefits’.4
The promotion of population-based screening may result in
unrealistic expectations, and truly informed consent may there-
fore be difficult to achieve. For example, women may erroneously
believe that screening prevents breast cancer rather than
detecting cancer at an earlier stage. A recent survey in Geneva
showed that only 20% of women assessed screening efficacy
realistically.5 We examined women’s perceptions on the likely
benefits of mammography screening in four industrialized
nations, the US, the UK, Italy, and Switzerland, countries which
differ with respect to national screening policies and the
implementation of screening programmes.
Methods
A survey of women’s understanding of the likely benefits of
mammography screening was performed in the US, UK, Italy,
and Switzerland during October and November 1999. The UK
implemented a national breast cancer screening programme in
1988 with an annual uptake rate of about 70% among the
target group of women aged 50–64 years.6 In Italy there are 
52 regional programmes involving women aged 50–69 years.7
The US and Switzerland do not have national population-based
programmes, however, opportunistic screening or case finding
is widespread in both countries.
Trained interviewers from an independent survey company
conducted computer-assisted telephone interviews. A random
digit dialling method was used to produce telephone numbers
and contact households.8 A sample size of 1000 interviews per
country was considered adequate to detect meaningful differ-
ences in knowledge levels between countries and groups of
women defined by socio-demographic characteristics. No
formal sample size calculation was performed. All phone calls
were made between 5:30 pm and 8:30 pm local time. This time
window was chosen to make sure that women working outside
the house would also be included. When a woman was contacted
she was asked whether she would be willing to participate in a
survey on breast cancer screening. She was advised that the
interview would last about 5 minutes. Response rates were
calculated as the proportion of contacted women who answered
all three questions. Reasons for non-participation were not
recorded.
Three closed questions were asked relating to whether screen-
ing prevents breast cancer, what reduction in breast cancer
mortality can be achieved among women aged 50 years, and
how many deaths can be prevented among 1000 women
screened for 10 years (Table 1). These questions were developed
in Italian and piloted in 82 women in Bellinzona, Switzerland.
The final version was translated to English, French, and German.
The correct answer to the first question was ‘mammography
screening does not have any influence on the risk of contracting
breast cancer’. Based on a meta-analysis of randomized controlled
trials which showed a reduction in breast cancer mortality of
26% (95% CI: 17%, 34%), the most appropriate answer to the
second question was that ‘screening reduces breast cancer mor-
tality in women aged 50 years by about a quarter’.9 Finally,
based on this risk reduction and the breast cancer mortality
rates published by WHO for women aged 50 years,10 it can be
assumed that between 5.1 deaths (Italy) and 6.7 deaths (UK)
could be prevented among 1000 women aged 50 screened
every 2 years for 10 years. The correct answer to the third
question therefore was that ‘about five deaths can be prevented’.
This is higher than the widely quoted figure,11 from random-
ized trials, of 1 death prevented per 1000 women screened for
10 years, because we included in our calculation all women
aged 50 years. The elderly, who have high breast cancer
mortality rates, were generally excluded from trials.
We computed a knowledge score with a range of 0 to 3 by
adding the number of correct answers. We used multivariate
ordered logistic regression to estimate the relationship between
the ordinal score variable and five independent variables: 
age group (15–29, 30–39, 40–49, 50–59, 60 years), level of
education (lower versus higher), occupation (full-time, part-
time, none), history of mammography in the past 2 years, and
country. Higher education was defined as completed secondary
school and above. We used ordered logistic regression (also
known as proportional odds regression),12 to model the
cumulative response probabilities of giving k correct answers
(cumpK). The model coefficients can be interpreted as odds
ratios (OR) comparing the odds of cumpK for different levels of
the predictor variable. An OR greater (smaller) than 1 shifts the
distribution of correct answers upwards (downwards) whereas
an OR of 1 indicates that the variable does not affect the dis-
tribution of correct answers. We computed tests of interaction
to examine whether the effect of socio-demographic variables
(age, educational level, occupation, history of mammography)
on knowledge scores differed across countries by including
interaction terms in the model. Standard logistic regression
analyses were performed to investigate determinants of correct
answers to the three individual questions. All analyses were
performed using the Stata software package (version 8, Stata
Corporation, College Station, USA).13
Results
A total of 5964 women were contacted and 4140 women (69%)
participated. Response rates were 69% for the US (1003 of 1443
contacted women), 70% in the UK (1108 out of 1578 women),
70% for Italy (1001 of 1431 women), and 68% for Switzerland
(1028 of 1512 women). A total of 1599 (39%) women in the
four samples were aged 50, 2613 (63%) had completed sec-
ondary school, 1879 (45%) were in full or part-time jobs, and
1455 (35%) had undergone mammography in the past 2 years.
Only a minority of women (26%) correctly indicated that
screening does not have any influence on the risk of contracting
breast cancer (Table 1). Even smaller proportions of women
expected a reduction in mortality close to the estimate from
randomized controlled trials (19%). Women resident in the US
were more likely to answer the first question correctly than
women from the other countries. Conversely, respondents in
the US less often gave the appropriate answer to the second
question. Few women (4% overall) answered the last question
on the absolute number of deaths prevented correctly, with the
surveys in continental Europe yielding a slightly higher propor-
tion of correct answers. For all three questions the differences
between countries continued to be evident in multivariate
logistic regression analyses adjusted for age, educational level,
occupation, and history of mammography (tables available from
authors).
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Table 2 gives the distribution of knowledge scores in each
country for all women and separately for women aged 40–49
years, 50–59 years, and 60 years. Overall, the majority of
women did not give any correct answer (59%). There was a
tendency for older women to be less knowledgeable than young
and middle-aged women. The results from univariate and
multivariate ordinal logistic regression analyses are shown in
Table 3. In univariate analysis women aged 50 years had lower
knowledge scores than younger women, but this difference 
was attenuated in multivariate analysis. Similarly, women who
did not work and women with a history of mammography had
lower scores in univariate analysis, with associations attenuated
in multivariate analysis. In univariate and multivariate analyses,
women with higher educational levels had higher scores than
women with less education and, compared with women in the
US, respondents in Italy and the UK had lower knowledge scores.
Knowledge in Switzerland was comparable to the US. There
was some evidence that the effect of a history of mammography
(P = 0.024 by test of interaction), and the effect of educational
level (P = 0.015) differed across countries. In analyses stratified
by country, the effect of a previous mammography on know-
ledge scores was stronger in Italy (OR = 0.71, 95% CI: 0.50,
1.00) but weaker in Switzerland (OR = 0.78, 95% CI: 0.58,
1.06) and the US (OR = 0.87, 95% CI: 0.63, 1.21), and in the
opposite direction in the UK (OR = 1.17, 95% CI: 0.83, 1.67).
The effect of higher levels of education was strong in the US
(OR = 1.87, 95% CI: 1.43, 2.47) and the UK (OR = 1.70, 95%
CI: 1.26, 2.30) but weaker in Switzerland (OR = 1.33, 95% CI:
0.98, 1.80) and absent in Italy (OR = 0.99, 95% CI: 0.73, 1.33).
Discussion
To our knowledge this is the first international survey of women’s
perceptions of the benefits of breast cancer screening which
uses common methods in random samples of the general popu-
lation. We found that in the US and three European countries
women clearly overestimated the benefits that can be realistically
expected from mammography screening. This was somewhat
more pronounced in the UK and Italy, the two countries with 
a National Health Service and established national or regional
population-based screening programmes, than in the US or
Switzerland, countries with a strong private health care sector
where women are screened on an opportunistic basis. Centrally
organized screening programmes are governed by coverage
targets, which determine, for example, payment to general
practitioners. It seems possible that this may act as a deterrent
to giving complete and balanced information.14,15
Unsurprisingly, better educated women tended to provide
more correct answers than women with lower educational
attainment. We were interested in the effect of invitations to
undergo mammography screening and therefore included
women aged 50 years as well as younger women. There was
some evidence that women in the age groups targeted by
screening programmes were less well informed than younger
Table 1 Women’s perception of the benefits of mammography screening in four countries
US UK Italy Switzerland All women
N = 1003 N = 1108 N = 1001 N = 1028 N = 4140
Question No. (%) No. (%) No. (%) No. (%) No. (%)
1. Mammography is an X-ray examination of the breasts. 
Which of the following statements concerning mammography 
reflects your opinion? Regular mammography every 
2 years in women who are well:
• prevents the risk of contracting breast cancer 262 (26) 191 (17) 325 (33) 101 (10) 879 (21)
• reduces the risk of contracting breast cancer 315 (31) 571 (52) 476 (48) 569 (55) 1931 (47)
• does not have any influence on the risk
of contracting breast cancera 369 (37) 243 (22) 165 (16) 279 (27) 1056 (26)
• don’t know 57 (6) 103 (9) 35 (3) 79 (8) 274 (7)
2. In your opinion, to what extent can mammography 
reduce breast cancer deaths among women aged 50 
screened every 2 years for 10 years?
• regular mammography hardly reduces breast cancer deaths 36 (4) 48 (4) 35 (4) 72 (7) 191 (5)
• reduces mortality due to breast cancer 
by about a quartera 123 (12) 241 (22) 173 (17) 251 (24) 788 (19)
• by about half 336 (33) 354 (32) 324 (32) 358 (35) 1372 (33)
• by about three-quarters 288 (29) 187 (17) 201 (20) 154 (15) 830 (20)
• prevents practically all deaths due to breast cancer 93 (9) 53 (5) 160 (16) 48 (5) 354 (9)
• don’t know 127 (13) 225 (20) 108 (11) 145 (14) 605 (15)
3. In your opinion, how many deaths due to breast cancer 
can be prevented among 1000 women aged 50 who 
have regular mammography every 2 years for 10 years?
• no deaths prevented 9 (1) 14 (1) 16 (2) 36 (4) 75 (2)
• about 5 deaths preventeda 27 (3) 28 (3) 40 (4) 52 (5) 147 (4)
• about 10 deaths prevented 48 (5) 60 (6) 52 (5) 83 (8) 243 (6)
• about 20 deaths prevented 83 (8) 115 (10) 91 (9) 93 (9) 382 (9)
• about 40 deaths prevented 117 (12) 153 (14) 210 (21) 148 (14) 628 (15)
• about 80 deaths prevented 151 (15) 111 (10) 176 (18) 115 (11) 553 (14)
• more than 100 deaths prevented 455 (45) 302 (27) 257 (26) 269 (26) 1283 (31)
• don’t know 113 (11) 325 (29) 159 (16) 232 (23) 829 (20)
a Correct or most appropriate answer.
women, and that women who recently underwent screening
were less well informed than women who did not. The lower
knowledge scores in older women was partly explained by lower
levels of educational attainment in this group. Interestingly, an
analysis of US women’s magazines found that the information
provided is persuasive and prescriptive in magazines aimed at
lower educational levels but more balanced and informative in
publications read by women with higher education.16
An Australian study of 58 pamphlets on mammography
screening found that benefits were generally expressed as relative
risk reductions and only a minority mentioned the possibility of
false positive or false negative tests.17 No leaflet gave absolute
risk reductions or the number of women that need to be screened
to avoid one death. Patients, purchasers, and doctors consider
an intervention to be more desirable when effectiveness data is
presented in relative rather than absolute terms.18–20 In an
earlier survey,21 we found that the public’s willingness to par-
ticipate in a hypothetical screening programme is clearly influ-
enced by the quality and extent of the information provided.
Our study has a number of limitations. It consisted of three
questions on the likely benefits of screening only, and did not
examine the awareness of adverse effects, including the conse-
quences of exposure to radiation and of false positive or false
negative test results. Indeed, it could be argued that by exclus-
ively addressing the benefits of screening our survey may have
contributed to unrealistic expectations. An Australian study
found that women also have unrealistically high expectations 
of the sensitivity of screening mammography, with about 40%
of women reporting that screening should detect all cancers
(sensitivity of 100%).22 More recently, a study of women in 
the US reported that women were aware and tolerant of false
positive mammography results although few had heard about
ductal carcinoma in situ.23
The questionnaire was developed in consultation with health
professionals with expertise in this area. These experts agreed
that all three questions were relevant, although we did not
assess their judgements formally. We discussed an early draft of
the questionnaire with six women of different educational
levels and performed a pilot study in a larger group of women.
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Table 2 Distribution of correct or most appropriate answers according to country in all women and women of different age groups
US UK Italy Switzerland All women
No. of correct or most appropriate answers No. (%) No. (%) No. (%) No. (%) No. (%)
All ages
0 552 (55) 676 (61) 683 (68) 552 (54) 2463 (59)
1 389 (39) 357 (32) 266 (27) 379 (37) 1391 (34)
2 56 (6) 70 (6) 44 (4) 88 (9) 258 (6)
3 6 (1) 5 (1) 8 (1) 9 (1) 28 (1)
Women aged 40–49 years
0 99 (48) 100 (57) 120 (69) 111 (55) 430 (57)
1 93 (45) 63 (36) 43 (25) 69 (34) 268 (36)
2 14 (7) 10 (6) 8 (5) 17 (9) 49 (6)
3 2 (1) 1 (0.6) 2 (1) 3 (2) 8 (1)
Women aged 50–59 years
0 118 (59) 88 (62) 117 (74) 106 (63) 429 (64)
1 70 (35) 46 (32) 33 (21) 45 (27) 194 (29)
2 12 (6) 8 (6) 7 (4) 16 (9) 43 (6)
3 1 (0.5) 1 (0.7) 1 (0.6) 2 (1) 5 (1)
Women aged 60 years
0 160 (61) 165 (64) 161 (74) 104 (55) 590 (64)
1 90 (34) 76 (30) 49 (22) 70 (37) 285 (31)
2 12 (5) 15 (6) 7 (3) 14 (7) 48 (5)
3 2 (0.8) 1 (0.4) 1 (0.5) 1 (0.5) 5 (0.5)
Age missing in one woman.
Percentages do not always add up to 100% due to rounding error.
Table 3 Probability of a larger number of correct or appropriate
answers. Results from univariate and multivariate ordinal logit
regression analyses
No. of Odds ratio (95% CI)
womena Crude Adjustedb
Age (year groups)
15–29 963 1.00 (ref.) 1.00 (ref.)
30–39 822 1.00 (0.83, 1.20) 0.97 (0.80, 1.17)
40–49 755 1.00 (0.83, 1.21) 1.02 (0.84, 1.25)
50–59 671 0.76 (0.63, 0.93) 0.83 (0.66, 1.04)
60 928 0.76 (0.63, 0.91) 0.88 (0.71, 1.08)
Education
Lower 1497 1.00 (ref.) 1.00 (ref.)
Higher 2613 1.63 (1.43, 1.85) 1.44 (1.25, 1.66)
Occupation
Full time 1106 1.00 (ref.) 1.00 (ref.)
Part time 773 1.01 (0.85, 1.22) 1.03 (0.85, 1.23)
Does not work 2195 0.82 (0.71, 0.94) 0.98 (0.84, 1.15)
History of mammographyc
No 2664 1.00 (ref.) 1.00 (ref.)
Yes 1455 0.85 (0.75, 0.96) 0.86 (0.74, 1.01)
Country
US 1108 1.00 (ref.) 1.00 (ref.)
UK 1003 0.81 (0.69, 0.96) 0.73 (0.60, 0.87)
Italy 1001 0.59 (0.50, 0.71) 0.61 (0.50, 0.74)
Switzerland 1028 1.11 (0.94, 1.31) 0.98 (0.82, 1.18)
a Due to missing data numbers do not always add up to the total of 4140.
b Adjusted for all variables in the table with a total of 4060 women in the
analysis.
c Having had a mammography in the last 2 years.
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